Navigating the complex landscape of epilepsy drug discovery requires moving beyond traditional approaches. As a spectrum of disorders characterized by recurrent seizures, epilepsy's profound heterogeneity—rooted in everything from specific channel mutations to broad synaptic dysregulation—means that effective preclinical models must capture a new level of biological nuance. The demand is for platforms that are not only scalable but also highly predictive and directly translatable to human pathology.
At Creative Biolabs, we thrive on this complexity. For more than 20 years, we have partnered with industry pioneers, recognizing that high-fidelity models are the catalyst for therapeutic breakthroughs. Our Epilepsy & Seizure Cell Model portfolio embodies this principle. These are not mere reagents, but fully validated, assay-ready systems engineered to provide critical insights, de-risk your pipeline, and shorten the journey from benchtop to breakthrough.
Details on all offerings are in the complete Product List.
We offer a diverse selection of models to meet your specific research needs.
Types | Description |
---|---|
iPSC-Derived Glutamatergic Neurons | Ideal for studying mechanisms of hyperexcitability. |
iPSC-Derived GABAergic Neurons | Perfect for investigating inhibitory circuit dysfunction. |
Defined Co-Cultures | These are mixed populations of glutamatergic and GABAergic neurons to create more complex, physiologically relevant circuits. |
Astrocyte Cultures | For studying the role of glia in neuronal health and seizure modulation. |
Genetically-Engineered Disease Models | A catalog of CRISPR-edited lines for monogenic epilepsies like Dravet Syndrome (SCN1A) and developmental epileptic encephalopathies (KCNQ2, CDKL5). |
Wild-Type & Isogenic Controls | The essential baseline controls for rigorous, interpretable science. |
Custom Model Development | We offer services to create custom genetic models tailored to your specific research target. |
Partnering with Creative Biolabs provides a distinct competitive edge for your research programs.
Utilize human-derived models that overcome species-specific differences, increasing the likelihood of clinical translation.
Rigorous QC and manufacturing standards ensure minimal lot-to-lot variability, leading to more consistent and reliable experimental outcomes.
Bypass the time-consuming process of iPSC differentiation and characterization. Our ready-to-use models allow you to move directly to your functional assays.
Our models are optimized for multi-well plate formats, making them ideal for large-scale compound screening and neurotoxicity studies.
Gain access to our team of Ph.D.-level scientists to assist with experimental design, data interpretation, and troubleshooting.
Our models are versatile tools suitable for a wide range of applications across the research and development pipeline.
Applications | Description |
---|---|
Disease Modeling | Investigate the cellular and network pathophysiology of specific genetic epilepsies. |
Drug Discovery & Compound Screening | Perform high-throughput screening (HTS) to identify novel anti-epileptic compounds that modulate neuronal excitability. |
Mechanism of Action (MoA) Studies | Elucidate how lead compounds exert their therapeutic effects at the cellular level. |
Target Identification & Validation | Use genetic models to confirm the role of specific ion channels or proteins in seizure generation. |
Neurotoxicity Assessment | Screen compounds for pro-convulsant liabilities early in the development process. |
Personalized Medicine Research | Study patient-specific mutations to explore tailored therapeutic strategies. |
The challenge of epilepsy demands a higher standard of preclinical tools. At Creative Biolabs, we deliver on that demand. Our Epilepsy & Seizure Cell Model Products are more than just reagents; they are integrated, validated systems designed to generate decision-driving data.
By partnering with us, you gain an extension of your own research team—one with the expertise, technology, and commitment to quality required to navigate the complexities of epilepsy drug discovery. Contact our scientific team today for a confidential consultation. Let's discuss your specific targets, explore our models' capabilities, and design a study that will unlock the full potential of your pipeline.
Discover our research tools for other significant disease areas by exploring the categories linked below.
Reference